The effect of somatostatin for treatment of post hepatectomy liver failure (PHLF)
Not Applicable
Recruiting
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0001977
- Lead Sponsor
- Korea University Anam Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1. Patients with PHLF without regard primary disease.
2. Ability to provide written informed consent
Exclusion Criteria
1. Concomitant surgery for another intraabdominal organs.
2. Severe renal disease requiring dialysis.
3. Patients with coagulation disorders or taking warfarin.
4. Immunosuppressed patients or the patients with autoimmune disorders.
5. Women with pregnant, breast-feeding.
6. Hypersensitivity to somatostatin.
7. Patients treated with other investigational product within 30 days at the consents are obtained.
8. Patients with a significantly reduced cognitive abilities.
9. Not eligible to participate for study at the discretion of investigator.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method in hospital mortality
- Secondary Outcome Measures
Name Time Method Complication rate;Time to recovery from PHLF (days)